{
    "URL": "https://doi.org/10.1371/journal.pntd.0008429",
    "Published": "July 20, 2020",
    "Subject_Areas": [
        "Leishmaniasis",
        "Kala-azar",
        "Drug therapy",
        "Medical risk factors",
        "Epidemiology",
        "Lesions",
        "Amphotericin",
        "Diagnostic medicine"
    ],
    "Authors": {
        "Vishal Goyal": [
            "Drugs for Neglected Diseases initiative (DNDi), New York, United States of America"
        ],
        "Vidya Nand Rabi Das": [
            "Division of Clinical Medicine, Rajendra Memorial Research Institute of Medical Sciences (RMRI), Patna, Bihar, India"
        ],
        "Shambhu Nath Singh": [
            "Sadar Hospital Chapra, Saran, Bihar, India"
        ],
        "Ravi Shankar Singh": [
            "Sadar Hospital Chapra, Saran, Bihar, India"
        ],
        "Krishna Pandey": [
            "Division of Clinical Medicine, Rajendra Memorial Research Institute of Medical Sciences (RMRI), Patna, Bihar, India"
        ],
        "Neena Verma": [
            "Division of Clinical Medicine, Rajendra Memorial Research Institute of Medical Sciences (RMRI), Patna, Bihar, India"
        ],
        "Allen Hightower": [
            "Independent consultant, Bangkok, Thailand"
        ],
        "Suman Rijal": [
            "Drugs for Neglected Diseases initiative (DNDi), New Delhi, India"
        ],
        "Pradeep Das": [
            "Division of Clinical Medicine, Rajendra Memorial Research Institute of Medical Sciences (RMRI), Patna, Bihar, India"
        ],
        "Jorge Alvar": [
            "Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"
        ],
        "Caryn Bern": [
            "School of Medicine, University of California San Francisco, San Francisco, California, United States of America"
        ],
        "Fabiana Alves": [
            "Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"
        ]
    }
}